THURSDAY, May 14 (HealthDay News) — The U.S. Food and Drug Administration has approved Cimzia (certolizumab pegol) to treat moderate-to-severe rheumatoid arthritis, Belgian drug maker UCB said Thursday in a news release.
Arthritis Information
THURSDAY, May 14 (HealthDay News) — The U.S. Food and Drug Administration has approved Cimzia (certolizumab pegol) to treat moderate-to-severe rheumatoid arthritis, Belgian drug maker UCB said Thursday in a news release.